Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
3
×
detroit blog main
detroit top stories
fda
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
approval
biogen
bristol-myers squibb
car-t
clinical study
democrats
donald trump
eli lilly
gene therapy
What
bio
days
roundup
airport
allogene
annual
apocalypse
august
beds
biotech
busy
cancer
celgene
crispr
decisions
devices
diversity
drugs
fallout
fda
gone
home
hot
immunotherapy
investors
ipo
j.p
jpm
juno
legacy
million
nearly
new
news
nods
notes
opioid
past
price
regulatory
Language
unset
Current search:
celgene
×
novartis
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
